Beyond Air (NASDAQ:XAIR) Earns “Buy” Rating from D. Boral Capital

Beyond Air (NASDAQ:XAIR)‘s stock had its “buy” rating reiterated by research analysts at D. Boral Capital in a report released on Wednesday,Benzinga reports. They currently have a $10.00 price target on the stock.

Other analysts also recently issued research reports about the company. Weiss Ratings restated a “sell (e)” rating on shares of Beyond Air in a research report on Monday, December 22nd. Rodman & Renshaw assumed coverage on shares of Beyond Air in a research report on Tuesday, January 20th. They set a “buy” rating on the stock. Finally, Wall Street Zen raised shares of Beyond Air to a “sell” rating in a research note on Saturday, March 7th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $10.00.

Beyond Air Trading Down 3.0%

NASDAQ XAIR opened at $0.81 on Wednesday. The stock’s 50-day simple moving average is $1.15 and its two-hundred day simple moving average is $1.55. Beyond Air has a twelve month low of $0.67 and a twelve month high of $6.40. The company has a quick ratio of 4.77, a current ratio of 5.12 and a debt-to-equity ratio of 2.65. The company has a market capitalization of $8.48 million, a price-to-earnings ratio of -0.15 and a beta of 0.41.

Beyond Air (NASDAQ:XAIR) last posted its quarterly earnings data on Friday, February 13th. The company reported ($0.85) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.54) by ($0.31). The firm had revenue of $2.19 million during the quarter, compared to analysts’ expectations of $2.15 million. Beyond Air had a negative return on equity of 268.82% and a negative net margin of 447.75%. Research analysts forecast that Beyond Air will post -0.79 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Geode Capital Management LLC lifted its stake in shares of Beyond Air by 1.5% in the 2nd quarter. Geode Capital Management LLC now owns 838,319 shares of the company’s stock valued at $144,000 after acquiring an additional 12,598 shares during the last quarter. Alyeska Investment Group L.P. bought a new position in Beyond Air during the 3rd quarter worth approximately $1,753,000. Osaic Holdings Inc. grew its position in Beyond Air by 26.4% during the 2nd quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock worth $29,000 after acquiring an additional 34,000 shares during the last quarter. Virtu Financial LLC purchased a new position in Beyond Air in the 3rd quarter worth approximately $48,000. Finally, Alpine Global Management LLC purchased a new position in Beyond Air in the 3rd quarter worth approximately $25,000. Hedge funds and other institutional investors own 31.50% of the company’s stock.

Beyond Air Company Profile

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.